Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.

Abstract
The effects of bromocriptine and levodopa were compared in a blind trial in 18 patients with Parkinson's disease. Optimal doses of the two drugs were given in identical capsules: there was no significant difference between the therapeutic effects. There were wide individual differences in response to the two drugs. Side effects were more common with bromocriptine because of side effects.

This publication has 4 references indexed in Scilit: